Enovis (ENOV) FCF Payout Ratio (2012 - 2014)

Enovis (ENOV) reported FCF Payout Ratio of 0.05 for Q1 2014, up 69.78% year-over-year from 0.03 in Q1 2013, and down 247.23% quarter-over-quarter from 0.03 in Q4 2013.

Enovis (ENOV) FCF Payout Ratio (2012 - 2014) Analysis & Trends

Enovis (ENOV) has 3 years of FCF Payout Ratio data on file, last reported at 0.05 in Q1 2014.

  • FCF Payout Ratio for Q1 2014 came in at 0.05, up 69.78% year-over-year; the trailing twelve-month figure through Dec 2014 was 0.01 (down 81.77% YoY), and the FY2019 annual result was 16.86, changed N/A from the prior year.
  • FCF Payout Ratio fell to 0.05 in Q1 2014 per ENOV's latest filing, from 0.03 in the prior quarter.
  • Over five years, FCF Payout Ratio peaked at 0.5 in Q3 2012 and troughed at 0.16 in Q1 2013.
  • A 3-year average of 0.06 and a median of 0.03 in 2013 frame the typical range for FCF Payout Ratio.
  • On a YoY basis, FCF Payout Ratio climbed as much as 460.84% in 2013 and fell as far as 895.32% in 2013.
  • A 3-year view of FCF Payout Ratio shows it stood at 0.12 in 2012, then plunged by 72.78% to 0.03 in 2013, then slumped by 247.23% to 0.05 in 2014.
  • Business Quant data shows ENOV's FCF Payout Ratio at 0.05 in Q1 2014, 0.03 in Q4 2013, and 0.06 in Q3 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Cover (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 1.20
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 0.81
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 0.40
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 0.08
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 0.25
10 Enovis 1.26 Bn 1.23 Bn 365.49 Mn -

Historic Data

Download Data
DateValue
Mar 28, 2014 -0.05
Dec 31, 2013 0.03
Sep 27, 2013 0.06
Jun 28, 2013 0.06
Mar 29, 2013 -0.16
Dec 31, 2012 0.12
Sep 28, 2012 0.50
Jun 29, 2012 -0.02
Mar 30, 2012 -0.02